Código QR (código de barras bidimensional)

Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review

IntroductionAlthough surgery is the preferred treatment for sarcomatoid hepatocellular carcinoma (SHC), the prognosis remains considerably poor due to early postoperative recurrence and metastasis. Reports on surgery after combined treatment with a tyrosine kinase inhibitor and anti-programmed cell...

ver descrição completa

Na minha lista:
Principais autores: Bin Liang, Tao Huang, Shao-Lei Kuang, Guang-Yuan Xie, Tian-Qi Liu, Yuan-Yuan Chen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2023-10-01
coleção:Frontiers in Oncology
Assuntos:
sarcomatoid hepatocellular carcinoma
anti-angiogenic therapy
anti-PD-1 antibody
surgery
combination therapy
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2023.1212013/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados